Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 687 results: Page 1 of 28


Tier Species Size Attr. GeneSet
Tier I 22 GS267845: GWAS Catalog Data for body mass index in Up to 13,627 European ancestry individuals
Tier I 56 GS267802: GWAS Catalog Data for age at menarche in 86,142 European ancestry female individuals, 557 Old Order Amish (founder/genetic isolate) female individuals, 1,103 Erasmus Rucphen (founder/genetic isolate) female individuals
Tier I 14 GS268251: GWAS Catalog Data for body mass index in 26,620 Japanese ancestry individuals
Tier I 39 GS268967: GWAS Catalog Data for body mass index in 34,744 European ancestry children
Tier III 453 GS218389: Chr 1 Locus for Factor 2 from PCA of COGA explaining 14% of variance in alcohol related characteristics.
Tier III 3625 GS218390: Alcoholism Susceptibility Chr 1
Tier IV 5317 GS407636: Differential gene expression comparison between Carnegie Stages (CS) 13 and 17 during human embryo craniofacial development
Tier IV 3583 GS407638: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development
Tier III 19901 GS407933: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_Log2FC
Tier III 19901 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 19111 GS407935: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_logFC
Tier III 19111 GS407936: Differentially expressed genes in human kidney tumors associated with extended opioid exposure_FDR
Tier III 17086 GS407944: Differentially expressed genes in opioid use disorder postmortem human brain_qvalue
Tier III 17086 GS407945: Differentially expressed genes in opioid use disorder postmortem human brain_log2FC
Tier III 18513 GS407948: Differentially expressed genes in humans nucleus accumbens associated with opioid use disorder_log2FC
Tier III 18278 GS407950: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_log2FC
Tier III 18278 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier III 19863 GS407964: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_logFC
Tier III 19863 GS407965: Differential gene expression in human postmortem tissue samples of the dorsolateral prefrontal cortex_qvalue
Tier IV 9363 GS408182: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, log2FC
Tier IV 10391 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 9299 GS408186: Differential gene expression comparison between Carnegie Stages (CS) 17 and 22 during human embryo craniofacial development, log2FC
Tier IV 9299 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10134 GS408189: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, log2FC
Tier IV 10134 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value